A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
23andMe and GlaxoSmithKline's partnership has uncovered half a dozen drug targets but also raised ethical questions, the Wall Street Journal reports.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
23andMe customers who have one of three common variants identified in reports can choose six family members to receive health and ancestry test kits.
CNBC reports that 23andMe is piloting a new program to incorporate customers' medical histories and lab tests with their genetic data.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
NatGeo will continue to conduct research using its database, which includes data on roughly a million individuals.
The Israeli online genealogy company recently expanded its ancestry genetic testing offering to include health information.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.